<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>By using flow cytometry, we studied CD103 and CD123 expression by the malignant cells in 300 B-cell <z:hpo ids='HP_0005523'>lymphoproliferative disorder</z:hpo> (BC-LPD) cases, including 114 hairy cell <z:hpo ids='HP_0001909'>leukemia</z:hpo> (HCL), 20 HCL variant (HCLv), 9 splenic marginal zone <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SMZL</z:e>; in 5, only CD103 was evaluated), 133 <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> (CLL), 3 follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (FL), and 21 mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> HCLs expressed uniform CD103 and bright CD123 </plain></SENT>
<SENT sid="2" pm="."><plain>Among the 20 HCLv cases, 20 (100%) were CD103+ and 8 (40%) were CD123+ (partial or dim) </plain></SENT>
<SENT sid="3" pm="."><plain>CD103 was negative in <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e>, FL, CLL, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SMZL</z:e> cases </plain></SENT>
<SENT sid="4" pm="."><plain>CD123 was positive in 1 (25%) of 4 SMZL, 3.8% of CLL (5/133), 7 (33%) of 21 MCL, and 1 (33%) of 3 FL cases </plain></SENT>
<SENT sid="5" pm="."><plain>CD103 is specific for HCL and HCLv </plain></SENT>
<SENT sid="6" pm="."><plain>CD123 expression is more widespread in BC-LPDs but is useful in conjunction with CD25 to differentiate HCLv from HCL </plain></SENT>
<SENT sid="7" pm="."><plain>These findings support the usefulness of CD123 and CD103 to aid in the differential diagnosis of BC-LPDs </plain></SENT>
</text></document>